Brain Monitoring Market to Grow with a CAGR of 6.59% through 2029
Increasing Research and Development Activities and a supportive
regulatory environment are the major drivers for the Global Brain Monitoring Market.
According to TechSci Research report, “Brain
Monitoring Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2029F”, the Global Brain Monitoring Market was valued at USD 3.46 billion
in 2023 and will see an impressive growth in the forecast period at a CAGR of
6.59% through 2029. This can be attributed to the awareness among individuals regarding Brain
Monitoring which has led to a favorable market. As individuals age, they become
more susceptible to age-related neurological disorders such as Alzheimer's
disease, Parkinson's disease, stroke, and dementia. The growing geriatric
population translates to a higher prevalence of these conditions, necessitating
the need for brain monitoring technologies for early detection, diagnosis, and
management.
Brain monitoring technologies enable early detection
of neurological changes and cognitive decline in the elderly population,
allowing for timely intervention and preventive measures to mitigate the
progression of neurological disorders. Regular monitoring of brain function
helps identify subtle changes in cognitive performance and facilitates
personalized interventions to maintain brain health and cognitive function. Older
adults often have multiple chronic health conditions and comorbidities that
increase their risk of neurological disorders and cognitive impairment. Brain
monitoring technologies play a crucial role in managing these complex health
conditions by providing insights into brain function, optimizing treatment
strategies, and reducing the risk of adverse outcomes associated with
neurological disorders.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "Global Brain Monitoring Market”
Ethical guidelines emphasize the
importance of obtaining informed consent from patients or research participants
before conducting brain monitoring procedures. Ensuring that individuals
understand the purpose, risks, and potential benefits of brain monitoring
technologies is essential for respecting autonomy and protecting patient
rights. Moreover, safeguarding patient privacy and confidentiality of sensitive
brain monitoring data is paramount, particularly in the context of data
storage, sharing, and secondary use for research or commercial purposes. Ethical
considerations arise regarding ownership, access, and control of brain
monitoring data generated during research or clinical practice. Clarifying data
ownership rights and establishing transparent data sharing policies are
critical for promoting trust, accountability, and responsible stewardship of
brain monitoring data. Balancing individual privacy rights with the collective
benefits of data sharing and research collaboration requires careful consideration
of ethical principles and legal frameworks. Vulnerable populations, such as
children, elderly individuals, individuals with cognitive impairments, and
individuals with mental health conditions, may face unique ethical challenges
in brain monitoring research. Safeguarding the rights, welfare, and dignity of
vulnerable research participants requires special protections, informed consent
procedures, and ethical oversight to mitigate potential risks and ensure
equitable access to research opportunities.
The Global Brain Monitoring Market is segmented into Device,
Application, End-User, regional distribution, and company.
Based on its Application, Huntington's disease (HD), also known as Huntington's
chorea, is a progressive and inherited neurological disorder characterized by
the gradual degeneration of nerve cells in certain areas of the brain. HD is
caused by a mutation in the huntingtin (HTT) gene, located on chromosome 4,
which results in the production of a mutant form of the huntingtin protein. The
mutation involves an expansion of a CAG trinucleotide repeat sequence within
the HTT gene, leading to the production of an abnormally long and toxic form of
the huntingtin protein. Involuntary, jerky movements (chorea) are one of the
most characteristic symptoms of Huntington's disease. Chorea can affect various
parts of the body, including the face, arms, legs, and trunk, and may worsen
with stress, excitement, or fatigue. HD often leads to progressive cognitive
impairment, including difficulties with concentration, memory, judgment, and
executive function. Individuals with HD may experience changes in behavior,
personality, and emotional regulation, including depression, anxiety,
irritability, and impulsivity.
Based on region, North America is dominating the
market. The region's well-established healthcare system and regulatory framework
facilitate the adoption and integration of innovative medical technologies.
Regulatory agencies such as the U.S. Food and Drug Administration (FDA) ensure
the safety, efficacy, and quality of brain monitoring devices, instilling
confidence among healthcare providers and patients. North America is witnessing
a rise in the prevalence of neurological disorders such as epilepsy, Alzheimer's
disease, Parkinson's disease, and stroke. As the population ages and the
incidence of neurological disorders increases, there is a growing demand for
advanced brain monitoring technologies to diagnose, treat, and manage these
conditions. There is a growing awareness of the importance of brain health
monitoring for early detection and intervention in neurological disorders.
Patients and healthcare providers are increasingly recognizing the value of
brain monitoring technologies in improving patient outcomes and quality of
life, driving demand for these solutions in North America.
Major companies operating in Global Brain
Monitoring Market are:
- Drägerwerk Ag & Co. Kgaa
- Masimo Corporation
- Cadwell Industries, Inc.
- Nurowave Systems, Inc.
- Neurosoft SA
- Cgx (A Cognionics Company)
- Natus Medical, Inc.
- Nihon Kohden Corporation
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Brain Monitoring Market offers substantial
opportunities for innovation, collaboration, and market growth aimed at
enhancing brain health, advancing neuroscience research, and improving patient
outcomes globally. By harnessing technological advancements, interdisciplinary
strategies, and patient-centric care models, the Brain Monitoring Market has
the potential to catalyze transformative shifts in healthcare delivery,
personalized medicine, and the management of brain health in the foreseeable
future", said Mr. Karan Chechi, Research Director of TechSci Research,
a research-based Global management consulting firm.
“Brain Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device (EEG, EMG, MEG, ICP, MRI, fMRI, CT), By End-User (Hospitals, Neurology Centers, Clinics & ASC), By Application (Traumatic brain injury (TBI), Stroke, Dementia, Headache disorders, Sleep disorders, Parkinson disease, Epilepsy, Huntington disease, Other diseases), By Region, and By Competition, 2019-2029F”, has evaluated
the future growth potential of Global Brain Monitoring Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Brain
Monitoring Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com